Effect of Biological Therapy for Psoriasis on the Development of Psoriatic Arthritis: A Population-Based Cohort Study

Yongtai Cho,Suneun Park,Kyungyeon Jung,Jeong-Eun Lee,Jieun Woo,Ju Hwan Kim,Ju-Young Shin
DOI: https://doi.org/10.1007/s40259-024-00689-8
IF: 7.744
2024-11-23
BioDrugs
Abstract:Evidence comparing the impact of various biologics for psoriasis on the progression to psoriatic arthritis (PsA) is limited. We therefore assessed the risk of PsA associated with interleukin (IL)-23 inhibitor, IL-17 inhibitor, or IL-12/23 inhibitor use compared with tumor necrosis factor (TNF) inhibitor use among patients with psoriasis.
oncology,pharmacology & pharmacy,immunology
What problem does this paper attempt to address?